Role of NF-κB activity in apoptotic response of keratinocytes mediated by interferon-γ, tumor necrosis factor-α, and tumor-necrosis-factor-related apoptosis-inducing ligand

Journal of Investigative Dermatology

Volumn 117, Issue 4, 2001, Pages 898-907

  Qin, J Z ^a   Bacon, P ^a   Chaturvedi, V ^a   Nickoloff, B J ^a  

^a Skin Cancer Research Laboratory   (United States)

Author keywords

Cell death; Cytokines; Death receptors; Skin cancer; Transcription factor

Indexed keywords

FAS ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIRUS VECTOR; APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; FADD PROTEIN, HUMAN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; I KAPPA B; MEMBRANE PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TNFSF10 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; KERATINOCYTE; NEWBORN; PRIORITY JOURNAL; PROTEIN INTERACTION; RETROVIRUS INFECTION; SIGNAL TRANSDUCTION; CELL CULTURE; CELL MEMBRANE; DOMINANT GENE; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; CELL MEMBRANE; CELL SURVIVAL; CELLS, CULTURED; DRUG COMBINATIONS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENES, DOMINANT; HUMANS; I-KAPPA B PROTEINS; INTERFERON TYPE II; KERATINOCYTES; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034740726     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2001.01477.x     Document Type: Article

References (66)

1. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L
2. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: Modulation by cytokines
3. Death receptors signaling and modulation
4. Apoptosis control by death and decoy receptors
5. Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation
6. An essential role for NF-κB in preventing TNF-α-induced cell death
7. Sunlight and sunburn in human skin cancer: p53, apoptosis and tumor promotion
8. Apoptosis in proliferating, senescent, and immortalized keratinocytes
9. Abnormal NF-κB signaling pathway with enhanced susceptibility to apoptosis in immortalized keratinocytes
10. Two human TNF receptors have similar extracellular, but distinct intracellular domain sequences
11. Protein kinase C delta is activated by caspase-dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinocytes
12. Expression of a dominant-negative mutant inhibitor -κBα of nuclear factor -κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo
13. Regional application of TNF-α in the treatment of cancer: A preclinical-clinical interactive program
14. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
15. The death domain: A module shared by proteins with diverse cellular functions
16. The death domain of tumor necrosis factor receptor 1 is necessary but not sufficient for Golgi retention of the receptor and mediates receptor desensitization
17. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B irradiated psoriatic plaques express Fas ligand
18. Role of p53 in UVB-induced apoptosis in human HaCaT keratinocytes
19. Fas ligand: A sensor for DNA damage critical in skin cancer etiology
20. Interferon-γ rescues TNF-α-induced apoptosis mediated by up-regulation of TNFR2 on EoL-1 cells
21. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase
22. Waf1/Cip1 by TNFα requires NF-κB activity and antagonizes apoptosis in Ewing tumor cells
23. Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand
24. Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis but not from ultraviolet radiation-induced apoptosis
25. Localization of tumor necrosis factor alpha (TNF-alpha) and its receptors in normal and psoriatic skin: Epidermal cells express the 55-kD but not the 75-kD TNF receptor
26. FADD is required for DR4- and DR5-mediated apoptosis
27. Fas/Fas ligand interactions contribute to UV-induced apoptosis in human keratinocytes
28. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes
29. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific
30. IKK1-deficient mice exhibit abnormal development of skin and skeleton
31. Cytokine network in psoriasis
32. Id-1 delay senescence but does not immortalize keratinocytes
33. Life and death signaling in epidermis following a planned cell death pathway involving a TRAIL that does not lead to skin cancer
34. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
35. Structural basis forself-association and receptor recognition of human TRAF2
36. L transgene promotes malignant conversion of chemically initiated skin papillomas
37. Role of NF-kappa B in the apoptotic-resistant phenotype of keratinocytes
38. Avoiding premature apoptosis of normal epidermal cells
39. Ultraviolet radiation-induced apoptosis is mediated by activation of CD95 (Fas/APO-1)
40. Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation
41. Interferon-γ treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program
42. Human tumor necrosis factor receptor p75/p80 (CD120b) gene structure and promoter characterization
43. Ultraviolet-B induced apoptosis of keratinocytes: Evidence for partial involvement of tumor necrosis factor-α in the formation of sunburn cells
44. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB
45. NF-κB determines localization and features of cell death in epidermis
46. Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1
47. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
48. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
49. Limb and skin abnormalities in mice lacking IKKα
50. The two different receptors for tumor necrosis factor mediate distinct cellular responses
51. Two TNF receptors
52. Apoptosis and the skin
53. Apoptosis in the pathogenesis and treatment of disease
54. UVB-induced activation of tumor necrosis factor (TNF) receptor 1/TNF receptor-associated factor-2 mediates activation of Rel proteins
55. The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation
56. p53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes
57. Signal-induced degradation of IκBα: Association with NF-κB and the PEST sequence in IκBα are not required
58. Squamous cell carcinomas and increased apoptosis in skin with inhibited rel/nuclear factor -κB signaling
59. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL
60. Tumoricidal activity of tumor necrosis factor related apoptosis-inducing ligand in vivo
61. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
62. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
63. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB
64. Death receptors in cutaneous biology and disease
65. Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo
66. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin